We are live on ! Find out more
ENFN

Enfusion, Inc.
ENFN

Delisted

ENFN was delisted on the 17th of April, 2025.

Back to rankings

64 hedge funds and large institutions have $931M invested in Enfusion, Inc. in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less funds holding

Funds holding: 67 → 64 (-3)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

38% less capital invested

Capital invested by funds: $1.51B → $931M (-$577M)

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
26
Reduced
15
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Ararat Capital Management
Connecticut
+$15.6M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$10.9M
3
Janus Henderson Group
Janus Henderson Group
+$6.18M
4
1WCM
12 West Capital Management
New York
+$4.58M
5
NCM
Nellore Capital Management
California
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$19M
2
BAMCO Inc
BAMCO Inc
New York
-$5.06M
3
Millennium Management
Millennium Management
New York
-$4.56M
4
SPPAM
Summit Partners Public Asset Management
Massachusetts
-$3.12M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.5M

ENFN Hedge Fund Activity: Q1 2022 in Review

64 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2022, worth a combined $931M — down 38% from $1.51B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ENFN and 16 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 26 added.

The largest buyer was Ararat Capital Management, adding an estimated $15.6M. The largest seller was Ameriprise, exiting entirely with an estimated $19M sold.

  • 64 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2022, down from 67 in Q4 2021.
  • Funds reported $931M of Enfusion, Inc. stock for Q1 2022, down 38% quarter-over-quarter.
  • 16 funds opened new Enfusion, Inc. positions in Q1 2022 and 19 closed out, a net change of -3 holders.
  • The largest Enfusion, Inc. buyer in Q1 2022 was Ararat Capital Management, an estimated $15.6M added.
  • The largest Enfusion, Inc. seller in Q1 2022 was Ameriprise, an estimated $19M sold.

Based on aggregated 13F filings for Q1 2022.